Servier Partners with Mitsubishi to Promote Diabetes Treatment in China

Life Science

BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market

Life Science

GenScript Starts Construction of Cell Therapy and Antibody Manufacturing Facility

Life Science

BioSense Acquires China Rights to Rexahn’s Pancreatic Cancer Drug in $226 Million Deal

Life Science

Chemistree Announces Partnership with New Jersey Medical Retail Cannabis License Applicant

Cannabis, Life Science

Catalent Buys Paragon for $1.2 Billion to Build its Gene Therapy Vector Capabilities

Life Science

Chi-Med Plans $500 Million IPO in Hong Kong, its Third Listing

Life Science

CStone Approved to Start China Bridging Trial of GIST Candidate

Life Science

Spectrum Cannabis Announces Partnership with CARP

Cannabis, Life Science

Ortoma Signs Exclusivity Agreement

Life Science

Hansoh Pharma Re-Files for $500 Million to $1 Billion Hong Kong IPO

Life Science

Creative Bio of Guangzhou Raises $45 Million for Early Colorectal Cancer Test

Life Science

Luqa Acquires China Rights to Topical Antibiotic from Spain’s Ferrer

Life Science

China Jo-Jo Drugstores Announces $10 Million Registered Direct Offering

Life Science

China’s Thalys and iCan: Israel-Cannabis Sign MOU for Co-investment in Cannabis and Hemp Related Startups

Cannabis, Life Science